In this regard, the selective inhibition of HDAC1, which is essential for glioma stem cell survival [58], was more effective than vorinostat in dysregulating cell cycle proteins, and several HDAC inhibitors displayed combinatorial effects with MEKi in promoting apoptosis. The gene discussed is HDAC9; the disease is glioma.